PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.
about
Molecular determinants of the cardiometabolic phenotype.Molecular insights and therapeutic targets for diabetic endothelial dysfunction.Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Effect of Atorvastatin and Pioglitazone on Plasma Levels of Adhesion Molecules in Non-Diabetic Patients With Hypertension or Stable Angina or Both.Interpretation of cardiovascular outcome trials in type 2 diabetes needs a multiaxial approach.
P2860
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
PROactive 07: pioglitazone in ...... esults of the PROactive study.
@ast
PROactive 07: pioglitazone in ...... esults of the PROactive study.
@en
type
label
PROactive 07: pioglitazone in ...... esults of the PROactive study.
@ast
PROactive 07: pioglitazone in ...... esults of the PROactive study.
@en
prefLabel
PROactive 07: pioglitazone in ...... esults of the PROactive study.
@ast
PROactive 07: pioglitazone in ...... esults of the PROactive study.
@en
P2093
P2860
P921
P1476
PROactive 07: pioglitazone in ...... results of the PROactive study
@en
P2093
Bernard Charbonnel
Erland Erdmann
John Dormandy
Massimo Massi-Benedetti
Robert Wilcox
P2860
P304
P407
P577
2007-01-01T00:00:00Z